What is a stock summary page? Click here for an overview.
Business Description
Cleopatra Hospital Co
ISIN : EGS729J1C018
Compare
Compare
Traded in other countries / regions
CLHO.Egypt IPO Date
2016-11-14Description
Cleopatra Hospital Co is a private hospital in Egypt. The company provides health and medical services, as well as the medical care of inpatients. Its operating segment based on hospitals includes Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawi Hospital, Al Shorouk Hospital, CHG for Medical Services, CHG Pharma for pharmacy management, CHG for Hospitals, Queens Hospitals and Al Kateb Hospitals. It generates maximum revenue from the Cleopatra Hospital Company segment. The company derives revenue from Accommodation and medical supervision, Surgeries, Outpatient clinics, Laboratories, Cardiac catheterization, Service charges, Radiology, Emergency, Oncology center, Pharmacy, Dentistry, Physiotherapy, Endoscopy, Cardiac tests, and Other services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.77 | |||||
| Debt-to-EBITDA | 1.66 | |||||
| Interest Coverage | 10.75 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 3.39 | |||||
| Beneish M-Score | -2.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 26.1 | |||||
| 3-Year EBITDA Growth Rate | 25.2 | |||||
| 3-Year EPS without NRI Growth Rate | 11.1 | |||||
| 3-Year FCF Growth Rate | -8.7 | |||||
| 3-Year Book Growth Rate | 6.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 35.98 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 35.08 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.63 | |||||
| 9-Day RSI | 26.59 | |||||
| 14-Day RSI | 32.29 | |||||
| 3-1 Month Momentum % | 0.24 | |||||
| 6-1 Month Momentum % | -0.71 | |||||
| 12-1 Month Momentum % | 28.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.29 | |||||
| Quick Ratio | 1.16 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 36.34 | |||||
| Days Sales Outstanding | 60.92 | |||||
| Days Payable | 71.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 3.3 | |||||
| Shareholder Yield % | -7.57 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.24 | |||||
| Operating Margin % | 21.82 | |||||
| Net Margin % | 13.07 | |||||
| FCF Margin % | -22.6 | |||||
| ROE % | 26.62 | |||||
| ROA % | 12.19 | |||||
| ROIC % | 19.65 | |||||
| 3-Year ROIIC % | 18.33 | |||||
| ROC (Joel Greenblatt) % | 33.54 | |||||
| ROCE % | 29.55 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.26 | |||||
| Forward PE Ratio | 14.67 | |||||
| PE Ratio without NRI | 20.08 | |||||
| Price-to-Owner-Earnings | 92.72 | |||||
| PEG Ratio | 1.3 | |||||
| PS Ratio | 2.22 | |||||
| PB Ratio | 4.03 | |||||
| Price-to-Tangible-Book | 4.75 | |||||
| Price-to-Operating-Cash-Flow | 8.56 | |||||
| EV-to-EBIT | 12.05 | |||||
| EV-to-EBITDA | 10.17 | |||||
| EV-to-Forward-EBITDA | 7.73 | |||||
| EV-to-Revenue | 2.61 | |||||
| EV-to-Forward-Revenue | 1.89 | |||||
| EV-to-FCF | -11.56 | |||||
| Price-to-GF-Value | 0.74 | |||||
| Price-to-Projected-FCF | 10.73 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.8 | |||||
| Price-to-Graham-Number | 2.06 | |||||
| Earnings Yield (Greenblatt) % | 8.3 | |||||
| FCF Yield % | -10.19 | |||||
| Forward Rate of Return (Yacktman) % | 18.99 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cleopatra Hospital Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil E£) | 4,895.378 | ||
| EPS (TTM) (E£) | 0.39 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.51 | ||
| 3-Year Sortino Ratio | 0.96 | ||
| Volatility % | 27.82 | ||
| 14-Day RSI | 32.29 | ||
| 14-Day ATR (E£) | 0.273201 | ||
| 20-Day SMA (E£) | 8.236 | ||
| 12-1 Month Momentum % | 28.7 | ||
| 52-Week Range (E£) | 5.91 - 9.44 | ||
| Shares Outstanding (Mil) | 1,445.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cleopatra Hospital Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cleopatra Hospital Co Stock Events
| Event | Date | Price (E£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cleopatra Hospital Co Frequently Asked Questions
What is Cleopatra Hospital Co(CAI:CLHO)'s stock price today?
The current price of CAI:CLHO is E£7.51. The 52 week high of CAI:CLHO is E£9.44 and 52 week low is E£5.91.
When is next earnings date of Cleopatra Hospital Co(CAI:CLHO)?
The next earnings date of Cleopatra Hospital Co(CAI:CLHO) is .
Does Cleopatra Hospital Co(CAI:CLHO) pay dividends? If so, how much?
Cleopatra Hospital Co(CAI:CLHO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers